🇺🇸 FDA
Pipeline program

CEA CAR-T cells

PBC017

Phase 2 mab active

Quick answer

CEA CAR-T cells for Solid Tumor is a Phase 2 program (mab) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
Solid Tumor
Phase
Phase 2
Modality
mab
Status
active

Clinical trials